 |
Cysteamine hydrochloride |
|---|---|
| Trade Name | Cystaran |
| Orphan Indication | Corneal cystine crystal accumulation in cystinosis patients |
| USA Market Approval | USA |
| USA Designation Date | 1997-08-19 00:00:00 |
| Sponsor | Leadiant Biosciences, Inc.;9841 Washingtonian Blvd, Suite 500;Gaithersburg, Maryland, 20878 |
